Tonix Pharmaceuticals Holding Corp’s filing revealed that its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on Aug 21 ’25. In the deal valued at $36.03 per share,418 shares were bought. As a result of this transaction, Taylor Carolyn E. now holds 418 shares worth roughly $15875.64.
Then, Treco James bought 250 shares, generating $9,000 in total proceeds. Upon buying the shares at $36.00, the Director now owns 250 shares.
Before that, LEDERMAN SETH bought 4,000 shares. Tonix Pharmaceuticals Holding Corp shares valued at $86,200 were divested by the Chief Executive Officer at a price of $21.55 per share. As a result of the transaction, LEDERMAN SETH now holds 4,005 shares, worth roughly $0.15 million.
Noble Capital Markets initiated its Tonix Pharmaceuticals Holding Corp [TNXP] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including ROTH Capital’s analysts, who increased its forecast for the stock in mid April from “a Neutral” to “a Buy”. ROTH Capital also remained covering TNXP and has increased its forecast on August 18, 2017 with a “Buy” recommendation from previously “Neutral” rating. ROTH Capital revised its rating on September 07, 2016. It rated TNXP as “a Neutral” which previously was an “a Buy”.
Price Performance Review of TNXP
On Friday, Tonix Pharmaceuticals Holding Corp [NASDAQ:TNXP] saw its stock jump 5.94% to $37.98. Over the last five days, the stock has lost -26.04%. Tonix Pharmaceuticals Holding Corp shares have fallen nearly -0.05% since the year began. Nevertheless, the stocks have risen 15.16% over the past one year. While a 52-week high of $130.00 was reached on 08/14/25, a 52-week low of $6.76 was recorded on 03/04/25.
Levels Of Support And Resistance For TNXP Stock
The 24-hour chart illustrates a support level at 35.99, which if violated will result in even more drops to 34.00. On the upside, there is a resistance level at 39.71. A further resistance level may holdings at 41.44.
How much short interest is there in Tonix Pharmaceuticals Holding Corp?
A steep rise in short interest was recorded in Tonix Pharmaceuticals Holding Corp stocks on 2025-07-31, dropping by 2994.0 shares to a total of 1.21 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 1.21 million shares. There was a decline of -0.25%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 17, 2016 when Oppenheimer resumed its ‘”an Outperform”‘ rating for the stock and retained the price target to $10.
